Treatment of muscle weakness in neuromuscular disorders - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Expert Review of Neurotherapeutics Year : 2016

Treatment of muscle weakness in neuromuscular disorders

Abstract

Weakness is one of the predominant clinical manifestations of neuromuscular disorders (NMDs), which strongly influences daily life, prognosis, and outcome of affected patients. One of the major therapeutic goals in NMD-patients is to completely resolve muscle weakness. Various treatment options are available and include physical therapy, electrotherapy, diet, drugs, avoidance or withdrawal of muscle-toxic and weakness-inducing agents, detoxification, stem-cell-therapy, plasma-exchange, respiratory therapy, or surgery. Most accessible to treatment is weakness from immune-mediated neuropathies, immune-mediated transmission-disorders, and idiopathic immune myopathies. Areas covered: This manuscript aims to summarize and discuss recent findings and future perspectives concerning the treatment of muscle weakness in NMDs. Data were obtained by a literature search in databases such as PubMed and Current-Contents. Expert commentary: Weakness is most easily treatable in acquired NMDs and in hereditary myopathies and neuropathies beneficial treatment options are also available. Research needs to be encouraged and intensified to further expand the spectrum of treatment options for weakness.
No file

Dates and versions

pasteur-01436296 , version 1 (16-01-2017)

Identifiers

Cite

Josef Finsterer, Sinda Zarrouk-Mahjoub. Treatment of muscle weakness in neuromuscular disorders. Expert Review of Neurotherapeutics, 2016, 16 (12), pp.1383-1395. ⟨10.1080/14737175.2016.1206471⟩. ⟨pasteur-01436296⟩

Collections

RIIP RIIP_TUNIS
23 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More